Gain Therapeutics (GANX) PT Lowered to $16 at B.Riley

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. INTU
2. DKS
3. ZM
4. META
5. SMTC
6. SPY
7. NCNO
8. JAZZ
9. NVDA
10. BOX

March 29, 2022 5:54 AM EDT
Get Alerts GANX Hot Sheet
Price: $1.83 -4.19%

Rating Summary:
    7 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 4 | Down: 18 | New: 11
Join SI Premium – FREE
B.Riley analyst Mayank Mamtani lowered the price target on Gain Therapeutics (NASDAQ: GANX) to $16.00 (from $21.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change